CN105777719A - Synthesis method of Daclatasvir - Google Patents

Synthesis method of Daclatasvir Download PDF

Info

Publication number
CN105777719A
CN105777719A CN201610191144.9A CN201610191144A CN105777719A CN 105777719 A CN105777719 A CN 105777719A CN 201610191144 A CN201610191144 A CN 201610191144A CN 105777719 A CN105777719 A CN 105777719A
Authority
CN
China
Prior art keywords
dacca
wei
reaction
synthetic method
dissolved
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201610191144.9A
Other languages
Chinese (zh)
Inventor
张中涛
吴其华
葛德培
刘涛
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ANHUI LIANCHUANG BIOLOGICAL MEDICINE Co Ltd
Original Assignee
ANHUI LIANCHUANG BIOLOGICAL MEDICINE Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ANHUI LIANCHUANG BIOLOGICAL MEDICINE Co Ltd filed Critical ANHUI LIANCHUANG BIOLOGICAL MEDICINE Co Ltd
Priority to CN201610191144.9A priority Critical patent/CN105777719A/en
Publication of CN105777719A publication Critical patent/CN105777719A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The invention relates to a synthesis method of Daclatasvir. The method comprises the following steps: step 1, performing a bromination reaction on 4.4-diacetyl biphenyl which serves as a raw material so as to obtain an intermediate 1; step 2, performing a substitution reaction on the intermediate 1 so as to obtain an intermediate 2; step 3, performing a cyclization reaction on the intermediate 2 so as to finally obtain the Daclatasvir. Compared with reported synthesis routes, a synthesis route of the method has the following advantages that the route is short, and the yield is high; general means such as suction filtration, extraction and concentration are adopted for aftertreatment, and aftertreatment is simple and convenient; severe-pollution and high-toxicity reagents such as bromine are avoided, and a process of repeatedly using an acetic acid washing reaction system is avoided.

Description

A kind of synthetic method of his Wei of Dacca
Technical field
The present invention relates to the synthetic method of a kind of hepatitis C virus NS5A inhibitor, be specifically related to his Wei of a kind of Dacca The synthetic method of (Daclatasvir dihydrocholide).
Background technology
Hepatitis C virus (HCV) is the main cause causing chronic hepatic diseases, there is no vaccine prevention HCV at present Infect.The existing standard of HCV infection nursing for treating scheme relates to individually or interferon-' alpha ' is used in combination with virazole, and this is controlled Treating relatively complicated, and have weak or other serious adverse reactions of cause, many patient for treatment can not sustained response.Dacca His Wei (Daclatasvir dihydrocholide) as a kind of high selectivity hepatitis C virus NS5A inhibitor, be have straight Connect the small-molecule drug of antivirus action, be also that the first NS5A clinical for hepatitis C replicates complex inhibitor.
Reported that relatively more schemes were Shawn K.Pack (US7728027B2, publication date 2010 06 month in recent years 01 day) et al. with 4.4-diacetyl biphenyl as raw material, through bromination reaction obtain intermediate 1, neutralize reaction obtain centre Body 2, cyclization intermediate 3, acid deprotection obtains intermediate 4, condensation reaction obtains target product.This route is in system Need to use the bromine that toxicity is big during standby intermediate 1, prepare the post processing needs of intermediate 3 repeatedly, substantial amounts of glacial acetic acid Washing, post processing are difficult to operation, prepare intermediate 4 needs and use the ethanol-hydrogen chloride of danger, and condensation reaction is used in a large number The condensing agent such as HOBT/EDCI/DCC, cause post processing to be difficult to obtain qualified product, and condensing agent can cause portion Dividing the generation of diastereomer, total recovery is 24.4%, and its synthetic route is as follows:
Song Baohui et al. (" synthesis of anti-hepatitis C new drug Daclatasvir dihydrocholide ", " Chinese Journal of New Drugs ", 2013,22 (22): 2679-2683) with biphenyl as raw material, obtain intermediate 1 through Friedel-Crafts reaction, neutralize during reaction obtains Mesosome 2, cyclization obtain intermediate 3, acid deprotection obtains intermediate 4 and condensation reaction obtains target product.This Route can produce large amount of sewage when preparing intermediate 1, when preparing intermediate 3 needs repeatedly, substantial amounts of glacial acetic acid washing, Post processing is difficult to operation, prepares intermediate 4 needs and uses the ethanol-hydrogen chloride of danger, and condensation reaction is used substantial amounts of The condensing agents such as HOBT/EDCI/DCC, cause post processing to obtain and take qualified product, and condensing agent can cause part The generation of diastereomer, total recovery is 23.9%, and its synthetic route is as follows:
Synthetic schemes (WO2011068941A2, publication date on 06 09th, 2011) is that first to synthesize this right earlier Claim the half of structure, then use the method for coupling to be recombinated by structure fragment, thus obtain target product;But therefore route exists When preparing intermediate 3 and intermediate 4, the coupling reagent of costliness used by needs and route is longer, be difficult to industrialized production and meet with Eliminating, its synthetic route is as follows:
Therefore, the synthetic method of his Wei of Dacca is existed and further improves and optimize demand, this just the present invention be able to The power completed and starting point place.
Summary of the invention
For the above-mentioned technical problem overcoming prior art to exist, the present inventor after having carried out substantial amounts of further investigation, Provide the synthetic method of his Wei of a kind of new Dacca, have that raw material is cheap and easy to get, route is short, yield is high, reaction easily behaviour Make, environmental pollution is little, the advantage of applicable industrialized production.
The present invention is achieved through the following technical solutions, the synthetic method of his Wei of a kind of Dacca, comprises the following steps:
Step one, obtains intermediate 1 for raw material through bromo-reaction with 4.4-diacetyl biphenyl;
Step 2, described intermediate 1 is substituted reaction and prepares intermediate 2;
Step 3, described intermediate 2 finally prepares his Wei of Dacca through cyclization;
As the preferred version of technique scheme, in step one, the building-up process of intermediate 1 is as follows: take 4.4-diethyl Acyl group biphenyl and DIPEA are dissolved in dichloromethane, and the dichloromethane solution of 0 DEG C of dropping TMSOTf and NBS is carried out Reaction, is poured into water whole reaction system after reaction completely, layering, and anhydrous sodium sulfate is dried, sucking filtration, concentrates and removes Dichloromethane obtains intermediate 1.It is further preferred that described 4.4-diacetyl biphenyl, DIPEA, TMSOTf and NBS Mol ratio be 1:(2.2~2.5): (2.1~2.4): (2.1~2.4).
As the preferred version of technique scheme, in step 2, the building-up process of intermediate 2 is as follows: take described centre Described in body 1 and reaction equation, L-PROLINE derivant is dissolved in acetonitrile, is slowly increased to room temperature anti-after 20 DEG C of dropping triethylamines Should, reaction is washed with saturated aqueous common salt after terminating, and organic layer obtains solid after concentrating, and to obtain final product.It is further preferred that institute State intermediate 1, L-PROLINE derivant, the mol ratio of triethylamine are 1:(2.2~2.5): (2.5~3.0).
As the preferred version of technique scheme, in step 3, his building-up process of Wei of Dacca is as follows: take described centre Body 2 and ammonium acetate are dissolved in toluene, and system is warming up to 90 DEG C of reactions, and reaction is cooled to room temperature, to reactant liquor after terminating Middle addition water, is layered after stirring 30min, and organic layer uses water, saturated aqueous common salt washing, sucking filtration, dry, concentration successively, Be subsequently adding ethanol solution hydrochloride, stirring, after through sucking filtration, dry after obtain his Wei of Dacca.It is further preferred that institute The mol ratio stating intermediate 2 and ammonium acetate is 1:(10~20).
Compared with prior art, beneficial effects of the present invention is as follows:
(1) present invention obtains intermediate 1 for raw material through bromo-reaction with 4.4-diacetyl biphenyl, substitution reaction prepares intermediate 2, cyclization finally prepares his Wei of Dacca, and total recovery reaches 61.8%, is significantly larger than and has reported total recovery;
(2) raw material (4.4-diacetyl biphenyl and L-PROLINE derivant) of synthetic route of the present invention is cheap and easily-available;
(3) synthetic route of the present invention is compared with the synthetic route reported, reaction easily operation, post processing is easy, locates afterwards Reason operation is all sucking filtration, extracts and the conventional means such as concentration;
(4) present invention synthesis is compared with the synthetic route reported, pollutes little, it is to avoid the pollutions such as use bromine are big, malicious The reagent that property is big, it also avoid the process of Reusability acetic acid washing reaction system;
(5) synthetic route of the present invention is because simplifying operating process, decreasing pollution, is suitable for industrial mass production.
Therefore, the synthesis technique of the present invention have that raw material is cheap and easy to get, route is short, yield is high, easy operation, environmental pollution Advantage little, that be suitable for industrialization large-scale production.
Detailed description of the invention
Below in conjunction with specific embodiment, the present invention is described in detail.Following example will assist in those skilled in the art Member is further appreciated by the present invention, but limits the present invention the most in any form.It should be pointed out that, the common skill to this area For art personnel, without departing from the inventive concept of the premise, it is also possible to make some deformation and improvement.These broadly fall into Protection scope of the present invention.
The reaction equation of embodiment 1-3 is as follows:
Embodiment 1
The present embodiment relates to the synthetic method of his Wei of a kind of Dacca, comprises the steps of:
Step one, the synthesis of intermediate 1
Take 4.4-diacetyl biphenyl (40g, 0.17mol) and DIPEA (53g, 0.41mol) and be dissolved in 1000mL In dichloromethane, 0 DEG C of dropping TMSOTf (0.37mol), drip and finish stirring 15 minutes, dropping NBS (0.39mol) Dichloromethane (200mL) solution, drip and finish 0 DEG C of stirring reaction 2h, completely, system is poured in 500mL water in reaction, Layering, anhydrous sodium sulfate are dried, sucking filtration, concentration removing dichloromethane, obtain intermediate 1 crude product, and toluene crystallization obtains 61 G solid, yield 91%;
MP:224-226 DEG C,1H NMR(400MHz,CDCl3):δ(ppm):7.96-7.84(m,4H),7.61-7.52(m,4H), 4.26 (s, 4H), HRMS (ESI): m/z [M+H]-394.93。
Step 2, the synthesis of intermediate 2
Take intermediate 1 (40g, 0.101mol) and L-PROLINE derivant (60g, 0.222mol) is dissolved in 400mL In acetonitrile, being slowly increased to room temperature reaction 4h after 20 DEG C of droppings triethylamine (0.278mol), reaction is complete, with 13% Saturated aqueous common salt washs, and dense the doing of organic layer directly carries out next step without purification;
Step 3, the synthesis of his Wei of Dacca
Take above-mentioned intermediate 2 and ammonium acetate (80g, the mol ratio of intermediate 2 and ammonium acetate is 1:10) is dissolved in 400mL In toluene, system is warming up to 90 DEG C, stirring reaction 12h, after reaction terminates, is cooled to room temperature, adds 200mL in system With 400mL water, stirring 30min, layering, organic layer washes with water successively, saturated common salt is washed, anhydrous sodium sulfate is dried, Dense dry addition 200mL ethanol, stirring is lower adds the 30mL ethanol solution containing 0.3mol hydrochloric acid, stirs 2h, sucking filtration, filter Cake washing with acetone is dried and is obtained 70g off-white color solid crude product, and methanol/acetone is recrystallized to give 56g white solid powder, Two step total recoverys of step 2 and step 3 are 68%.
MP:266-268 DEG C,1H NMR(400MHz,d6-DMSO):δ(ppm):12.03(s,2H),7.76(d,4H),7.62 (d,4H),7.45(s,2H),7.29(s,2H),5.03(t,2H),4.02(t,2H),3.76(m,4H),3.42(s,6H),2.10(m,2H),1.99 (m, 2H), 1.93 (m, 4H), 0.84-0.89 (d, 12H), HRMS (ESI): m/z [M+2Cl]-738.24。
Embodiment 2
The present embodiment relates to the synthetic method of his Wei of a kind of Dacca, comprises the steps of:
Step one, the synthesis of intermediate 1
Take 4.4-diacetyl biphenyl (40g, 0.17mol) and DIPEA (49g, 0.38mol) and be dissolved in 1000mL In dichloromethane, 0 DEG C of dropping TMSOTf (0.39mol), drip and finish stirring 15 minutes, dropping NBS (73g, 0.41mol) Dichloromethane (200mL) solution, drip and finish 0 DEG C of stirring reaction 2h, completely, system is poured in 500mL water in reaction, Layering, anhydrous sodium sulfate are dried, sucking filtration, concentration removing dichloromethane, obtain intermediate 1 crude product, and toluene crystallization obtains 62 G solid, yield 92%;
MP:224.5-226.5 DEG C,1H NMR(400MHz,CDCl3):δ(ppm):7.95-7.84(m,4H),7.62-7.52(m, 4H), 4.27 (s, 4H), HRMS (ESI): m/z [M+H]-394.94。
Step 2, the synthesis of intermediate 2
Take intermediate 1 (40g, 0.101mol) and L-PROLINE derivant (60g, 0.252mol) is dissolved in 400mL In acetonitrile, being slowly increased to room temperature reaction 4h after 20 DEG C of droppings triethylamine (25.5g, 0.302mol), reaction completely, is used The saturated aqueous common salt washing of 13%, dense the doing of organic layer directly carries out next step without purification;
Step 3, the synthesis of his Wei of Dacca
Take above-mentioned intermediate 2 and ammonium acetate (160g, the mol ratio of intermediate 2 and ammonium acetate is 1:20) is dissolved in 400mL In toluene, system is warming up to 80 DEG C, stirring reaction 15h, after reaction terminates, is cooled to room temperature, adds 200mL in system With 400mL water, stirring 30min, layering, organic layer washes with water successively, saturated common salt is washed, anhydrous sodium sulfate is dried, Dense dry addition 200mL ethanol, stirring is lower adds the 30mL ethanol solution containing 0.3mol hydrochloric acid, stirs 2h, sucking filtration, filter Cake washing with acetone obtains 74g crude white solid, and methanol/acetone is recrystallized to give 59g white solid powder, step 2 It is 71% with two step total recoverys of step 3.
MP:266-268.5 DEG C,1H NMR(400MHz,d6-DMSO):δ(ppm):12.02(s,2H),7.75(d,4H),7.62 (d,4H),7.45(s,2H),7.28(s,2H),5.03(t,2H),4.03(t,2H),3.76(m,4H),3.41(s,6H),2.10(m,2H),1.98 (m, 2H), 1.92 (m, 4H), 0.85-0.89 (d, 12H), HRMS (ESI): m/z [M+2Cl]-738.25。
Embodiment 3
The present embodiment relates to the synthetic method of his Wei of a kind of Dacca, comprises the steps of:
Step one, the synthesis of intermediate 1
Take 4.4-diacetyl biphenyl (40g, 0.17mol) and DIPEA (0.39mol) and be dissolved in 1000mL dichloro In methane, 0 DEG C of dropping TMSOTf (91g, 0.41mol), drip and finish stirring 15 minutes, dropping NBS (66g, 0.37 Mol) dichloromethane (200mL) solution, drips and finishes 0 DEG C of stirring reaction 2h, and completely, system pours 500mL in reaction In water, layering, anhydrous sodium sulfate are dried, sucking filtration, concentration removing dichloromethane, obtain intermediate 1 crude product, toluene crystallization Obtain 62g solid, yield 92%;
MP:225-226 DEG C,1H NMR(400MHz,CDCl3):δ(ppm):7.96-7.85(m,4H),7.60-7.52(m,4H), 4.27 (s, 4H), HRMS (ESI): m/z [M+H]-394.93。
Step 2, the synthesis of intermediate 2
Take intermediate 1 (40g, 0.101mol) and L-PROLINE derivant (60g, 0.237mol) is dissolved in 400mL In acetonitrile, being slowly increased to room temperature reaction 4h after 20 DEG C of droppings triethylamine (26g, 0.252mol), reaction completely, is used The saturated aqueous common salt washing of 13%, dense the doing of organic layer directly carries out next step without purification;
Step 3, the synthesis of his Wei of Dacca
Take above-mentioned intermediate 2 and ammonium acetate (120g, the mol ratio of intermediate 2 and ammonium acetate is 1:15) is dissolved in 400mL In toluene, system is warming up to 90 DEG C, stirring reaction 12h, after reaction terminates, is cooled to room temperature, adds 200mL in system With 400mL water, stirring 30min, layering, organic layer washes with water successively, saturated common salt is washed, anhydrous sodium sulfate is dried, Dense dry addition 200mL ethanol, stirring is lower adds the 30mL ethanol solution containing 0.3mol hydrochloric acid, stirs 2h, sucking filtration, filter Cake washing with acetone is dried and is obtained 72g off-white color solid crude product, and methanol/acetone is recrystallized to give 57g white solid powder, Two step total recoverys of step 2 and step 3 are 69%.
MP:266.5-268 DEG C,1H NMR(400MHz,d6-DMSO):δ(ppm):12.04(s,2H),7.76(d,4H),7.61 (d,4H),7.45(s,2H),7.28(s,2H),5.03(t,2H),4.02(t,2H),3.76(m,4H),3.41(s,6H),2.11(m,2H),1.99 (m, 2H), 1.94 (m, 4H), 0.84-0.88 (d, 12H), HRMS (ESI): m/z [M+2Cl]-738.23。
The ultimate principle of the present invention and principal character and advantages of the present invention have more than been shown and described.The technology people of the industry Member, it should be appreciated that the present invention is not restricted to the described embodiments, simply illustrating this described in above-described embodiment and description The principle of invention, without departing from the spirit and scope of the present invention, the present invention also has various changes and modifications, this A little changes and improvements both fall within scope of the claimed invention.Claimed scope is by appended claim Book and equivalent thereof define.

Claims (7)

1. the synthetic method of his Wei of Dacca, it is characterised in that comprise the following steps:
Step one, obtains intermediate 1 for raw material through bromo-reaction with 4.4-diacetyl biphenyl;
Step 2, described intermediate 1 is substituted reaction and prepares intermediate 2;
Step 3, described intermediate 2 finally prepares his Wei of Dacca through cyclization;
The synthetic method of his Wei of a kind of Dacca the most as claimed in claim 1, it is characterised in that in step one, intermediate 1 Building-up process as follows: take 4.4-diacetyl biphenyl and DIPEA be dissolved in dichloromethane, 0 DEG C dropping TMSOTf and The dichloromethane solution of NBS reacts, and whole reaction system is poured into water after reaction completely, layering, anhydrous slufuric acid Sodium is dried, sucking filtration, concentrates removing dichloromethane and obtains intermediate 1.
The synthetic method of his Wei of a kind of Dacca the most as claimed in claim 2, it is characterised in that described 4.4-diacetyl Biphenyl, the mol ratio of DIPEA, TMSOTf and NBS are 1:(2.2~2.5): (2.1~2.4): (2.1~2.4).
The synthetic method of his Wei of a kind of Dacca the most as claimed in claim 1, it is characterised in that in step 2, intermediate The building-up process of 2 is as follows: takes L-PROLINE derivant described in described intermediate 1 and reaction equation and is dissolved in acetonitrile, 20 DEG C Being slowly increased to room temperature reaction after dropping triethylamine, reaction is washed with saturated aqueous common salt after terminating, and organic layer is consolidated after concentrating Body, to obtain final product.
The synthetic method of his Wei of a kind of Dacca the most as claimed in claim 4, it is characterised in that described intermediate 1, L- Proline derivative, the mol ratio of triethylamine are 1:(2.2~2.5): (2.5~3.0).
The synthetic method of his Wei of a kind of Dacca the most as claimed in claim 1, it is characterised in that in step 3, Dacca he The building-up process of Wei is as follows: take described intermediate 2 and ammonium acetate is dissolved in toluene, and system is warming up to 90 DEG C of reactions, instead Should be cooled to room temperature after terminating, add water, be layered after stirring 30min in reactant liquor, organic layer is successively with water, saturated Brine It, sucking filtration, be dried, concentrate, be subsequently adding ethanol solution hydrochloride, stirring, after through sucking filtration, dry after Obtain his Wei of Dacca.
The synthetic method of his Wei of a kind of Dacca the most as claimed in claim 6, it is characterised in that described intermediate 2 and acetic acid The mol ratio of ammonium is 1:(10~20).
CN201610191144.9A 2016-03-29 2016-03-29 Synthesis method of Daclatasvir Pending CN105777719A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610191144.9A CN105777719A (en) 2016-03-29 2016-03-29 Synthesis method of Daclatasvir

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610191144.9A CN105777719A (en) 2016-03-29 2016-03-29 Synthesis method of Daclatasvir

Publications (1)

Publication Number Publication Date
CN105777719A true CN105777719A (en) 2016-07-20

Family

ID=56392199

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610191144.9A Pending CN105777719A (en) 2016-03-29 2016-03-29 Synthesis method of Daclatasvir

Country Status (1)

Country Link
CN (1) CN105777719A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017076358A1 (en) * 2015-11-06 2017-05-11 苏州晶云药物科技有限公司 New crystal form of imidazolyl biphenyl compound salt and preparation method thereof

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101778841A (en) * 2007-08-08 2010-07-14 百时美施贵宝公司 Be used for the synthetic method that is used for the treatment of the compound of hepatitis C
WO2011146401A1 (en) * 2010-05-17 2011-11-24 Intermune, Inc. Novel inhibitors of hepatitis c virus replication
CN102480971A (en) * 2009-09-04 2012-05-30 葛兰素史密丝克莱恩有限责任公司 Chemical compounds
WO2012087976A2 (en) * 2010-12-21 2012-06-28 Intermune, Inc. Novel inhibitors of hepatitis c virus replication
WO2012123298A1 (en) * 2011-03-11 2012-09-20 F. Hoffmann-La Roche Ag Antiviral compounds
CN103880823A (en) * 2012-12-21 2014-06-25 广东东阳光药业有限公司 Spiro compound serving as hepatitis c inhibitor and application thereof in medicine
CN104725365A (en) * 2013-12-23 2015-06-24 南京圣和药业股份有限公司 Hepatitis c virus (HCV) inhibitor and application thereof

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101778841A (en) * 2007-08-08 2010-07-14 百时美施贵宝公司 Be used for the synthetic method that is used for the treatment of the compound of hepatitis C
CN102480971A (en) * 2009-09-04 2012-05-30 葛兰素史密丝克莱恩有限责任公司 Chemical compounds
WO2011146401A1 (en) * 2010-05-17 2011-11-24 Intermune, Inc. Novel inhibitors of hepatitis c virus replication
WO2012087976A2 (en) * 2010-12-21 2012-06-28 Intermune, Inc. Novel inhibitors of hepatitis c virus replication
WO2012123298A1 (en) * 2011-03-11 2012-09-20 F. Hoffmann-La Roche Ag Antiviral compounds
CN103880823A (en) * 2012-12-21 2014-06-25 广东东阳光药业有限公司 Spiro compound serving as hepatitis c inhibitor and application thereof in medicine
CN104725365A (en) * 2013-12-23 2015-06-24 南京圣和药业股份有限公司 Hepatitis c virus (HCV) inhibitor and application thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
WIESLAW M. KAZMIERSKI等: "Novel Spiroketal Pyrrolidine GSK2336805 Potently Inhibits Key Hepatitis C Virus Genotype 1b Mutants: From Lead to Clinical Compound", 《J. MED. CHEM.》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017076358A1 (en) * 2015-11-06 2017-05-11 苏州晶云药物科技有限公司 New crystal form of imidazolyl biphenyl compound salt and preparation method thereof

Similar Documents

Publication Publication Date Title
CN106083773B (en) The preparation method of the fluoro- 2- methyl-D-ribo-gamma lactone of 3,5- dibenzoyl -2- deoxidation -2-
CN110950828B (en) Baicalein or derivatives thereof, preparation method and application
CN103183716B (en) Preparation method of tauro ursodesoxy cholic acid
CN104327138B (en) Preparation method of PSI-7977 intermediate compound
CN102659851B (en) Polyoxometallate-silhybridoxane hybridoxane compound and preparation method
CN101058535A (en) Di(7-hydrxyl-2,3-dihydro-1-1H-indeno)ether and the like, synthetic method and application
CN105906627A (en) Synthesis method of linagliptin intermediate
CN105777719A (en) Synthesis method of Daclatasvir
CN1115318A (en) Levo- and dextro-rotary chloroscouriline (tetrahydroprotoberberines) and application thereof
CN109422710A (en) A kind of preparation method of Suo Feibuwei fluorine lactone intermediate
CN105237516A (en) Preparation method of Ledipasvir
CN105367558B (en) Andrographolidume derivative and its preparation method and application
CN104693258B (en) Fluorescence-labeled nucleotides based on molecular glue and its purposes in DNA sequencing
CN108424389A (en) A kind of preparation method of Ivabradine impurity
CN108129366B (en) Antiviral compounds, methods of preparation and uses thereof
CN104188980B (en) O-(morpholinyl) ethyl derivative of Cleistanone Cleistanone, preparation method and its usage
CN104311518A (en) Preparation method for 6-methoxyscutellarin
CN109456375B (en) A kind of heterocycle compound containing monosaccharide groups and preparation method inhibiting hepatitis C virus
CN106366145A (en) Preparation method of (2'R)-2'-deoxy-2'-fluoro-2'-methyluridine
CN102070577B (en) 2-normal-butyl-3-(4-replaces propoxy-benzoyl)-5-substituted-amino cumarone and application thereof
CN106478653B (en) Mono- imidazole salt compound of isobide-and preparation method thereof
CN106279117A (en) A kind of synthetic method of Lei Dipawei intermediate and products thereof
CN104693066A (en) Anti-hepatitis B virus active phenylpropanoids adamantine ketoxime ester compound
CN111635358A (en) Preparation method of hydroxychloroquine
CN103880765A (en) Chemical synthesis method of 3-isoxazolyl benzyl acetate

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20160720